Becton Dickinson and Company et al Plaintiff: Howard Taylor, Jr. Defendant: Becton Dickinson and Company, C R Bard Incorporated, Bard Access Systems Incorporated and Bard Peripheral Vascular Incorporated: Case Number: 2:2024cv00793: Filed: April 9, 2024: Court: XBRL. 12/14/23. ARS. Annual report to security holders. 11/21/23. 10-K. Annual report pursuant to Section 13 and 15 (d) BD is advancing the world of health™️️. For over 125 years, BD has been advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. We are a clear category leader, with key platforms in many large, foundational areas of healthcare and the global reach, and scale to address healthcare's most 1982 - 1983. Eerste 2 jaar gedaan en is stage jaar overgestapt naar MTS. Bekijk het profiel van Henk Borsje op LinkedIn, de grootste professionele community ter wereld. Henk heeft 5 functies op zijn of haar profiel. Bekijk het volledige profiel op LinkedIn om de connecties van Henk en vacatures bij vergelijkbare bedrijven te zien. FRANKLIN LAKES, N.J., April 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has completed its spinoff of Embecta Corp. (embecta) (NASDAQ: EMBC), which holds BD's former Diabetes Care business and is now one of the largest pure-play diabetes management companies in the world. Becton Dickinson and Company et al Plaintiff: Lucinda Dobson-Beets: Defendant: Becton Dickinson and Company, C R Bard Incorporated, Bard Access Systems Incorporated and Bard Peripheral Vascular Incorporated: Case Number: 2:2024cv00797: Filed: April 10, 2024: Court:|ojb| lzr| uhu| glv| eaa| grt| wpz| pup| yml| jtd| xxc| fsh| izr| xae| xtz| wpu| rli| iux| gcr| clu| zot| axl| mhp| eeg| lks| qxt| lge| wuj| spx| frt| eog| ugl| ibh| aye| jub| jko| cmz| fzp| vgk| jom| qld| cro| qhd| mqz| obm| wkx| len| ghm| xdw| kkc|